Denosumab Demonstrated Superiority Over Zometa In Pivotal Phase 3 Head-To-Head Trial In Prostate Cancer Patients With Bone Metastases

Amgen announced that a pivotal, Phase 3, head-to- head trial evaluating denosumab versus Zometa (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints. Source: General Cancer News Articles Provided by Cancer Compass

Data From Ohio State University Advance Knowledge In Head And Neck Cancer
Medifocus, Inc. Announces Food And Drug Administration FDA Update For Its Pivotal Phase III Clinical Trial For Treatment Of Breast Cancer: Files Response To Two Remaining Questions
Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer
Scientists At Southern Illinois University Publish New Data On Head And Neck Cancer
GTx Announces Top Line Results Of Phase III Clinical Trial Evaluating Toremifene 20 mg For The Prevention Of Prostate Cancer In Men With High Grade PIN
Treatment For Melanomas Remain The Same
New Research On Head And Neck Cancer From Saitama Medical University
Studies Conducted At Magna Graecia University On Head And Neck Cancer Therapy Recently Published
Committee Recommends Continuation Of Phase III Study Of StemEx For Leukemia And Lymphoma
Amgen Preclinical Study Demonstrated Anti-Tumor Activity In Mammary Tumor Model
More spent per head in Scotland, but health benefits yet to show
Guided Therapeutics' LightTouch Cervical Scan Detected Disease Up To Two Years Earlier Than Pap, HPV And Biopsy In FDA Pivotal Clinical Trial
Initiation Of Phase I Combination Clinical Trial Of Brentuximab Vedotin SGN-35 For Front-Line Hodgkin Lymphoma
Research Results From Institute For Molecular Medicine Update Knowledge Of Head And Neck Cancer
U-M Study Achieves Reduced Side Effects In Head And Neck Cancer Treatment

Tags: Bone, Cancer, Demonstrated, Denosumab, HeadToHead, Metastases, patients, Phase, Pivotal, Prostate, Superiority, Trial, Zometa
Posted in Cancer on | There are currently No Comments

Cancer Cure Books

Sponsored Links

Denosumab Demonstrated Superiority Over Zometa In Pivotal Phase 3 Head-To-Head Trial In Prostate Cancer Patients With Bone Metastases

Related Posts:

Leave a Reply